Cancer Vaccine Current Events | Cancer Vaccine News | 10
|
| Page
10 of
112 |
2229 Results |
|
|
|
Sort By:
Page Views | Date |
Vaccinating boys against human papillomavirus not cost-effective
Persistent infection with high-risk types of human papillomavirus (HPV), a sexually transmitted virus, is known to be a cause of cervical cancer. view more (2009-10-09)
Study finds association between hepatitis B and pancreatic cancer
A new study has shown that evidence of past hepatitis B infection was twice as common in people with pancreatic cancer than in healthy controls. This study is the first to report an association between past exposure to the hepatitis B virus and pancreatic cancer, but researchers cautioned that more studies are necessary to evaluate the nature of... view more... (2008-09-30)
HIV vaccine regimen demonstrates modest preventive effect in Thailand clinical study
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand. view more (2009-09-24)
India continues to progress in AIDS vaccine development efforts
A second Phase I AIDS vaccine clinical trial in India was successfully completed, the Indian Council of Medical Research, the National AIDS Control Organization and the International AIDS Vaccine Initiative announced. The results of the trial of an MVA-based AIDS vaccine candidate (TBC-M4), which was conducted in Chennai, indicated that the... view more... (2008-08-18)
Pakistan introduces vaccine to prevent top child killer
This month, Pakistan is introducing a new combination vaccine that will protect its children against the bacterium Haemophilus influenzae type b (Hib) and four other common childhood diseases. view more (2008-11-03)
UCLA develops safer, more effective TB vaccine for HIV-positive people
UCLA scientists engineered a new tuberculosis (TB) vaccine specifically designed for HIV-positive people that was shown to be safer and more potent than the current TB vaccine in preclinical trials. view more (2008-10-24)
Malaria Vaccine Initiative And Apovia Inc. Partner To Pursue Rapid Development Of Novel Malaria Vaccine
A public-private partnership announced today promises to bring a powerful new malaria vaccine into human trials this year. The partnership between a San Diego-based biotechnology company, Apovia Inc., and the Malaria Vaccine Initiative at PATH (Program for Appropriate Technology in Health) is a multi-million dollar, multi-year agreement. The... view more... (2001-01-26)
Initial Results Show Pregnant Women Mount Strong Immune Response To One Dose of 2009 H1N1 Flu Vaccine
Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health. view more (2009-11-03)
Vaccine Blocks Malaria Transmission in Lab Experiments
Researchers at the Johns Hopkins Malaria Research Institute have for the first time produced a malarial protein (Pfs48/45) in the proper conformation and quantity to generate a significant immune response in mice and non-human primates for use in a potential transmission-blocking vaccine. view more (2009-07-23)
Researchers discover strategy for predicting the immunity of vaccines
In the first study of its kind, researchers at the Yerkes National Primate Research Center and Emory Vaccine Center, Emory University, have developed a multidisciplinary approach involving immunology, genomics and bioinformatics to predict the immunity of a vaccine without exposing individuals to infection. view more (2008-11-24)
Experimental flu vaccine appears promising in early tests
An influenza vaccine produced with the use of insect cells appeared safe and produced an immunogenic response in healthy adults, suggesting promise as an alternative to using embryonated eggs for the development of influenza vaccine. view more (2007-04-11)
Safer Flu Vaccine in Cold Conditions
Using cold temperatures could help make quicker, cheaper and safer influenza vaccines, according to Dr Alison Whiteley at the Society for General Microbiology's Spring Meeting in Edinburgh today, Monday 7 April 2003. view more (2003-04-02)
Hospitalizations because of chicken pox down dramatically since implementation of vaccine
Since the introduction of the varicella (chicken pox) vaccine in 1995, hospitalizations and doctor visits because of chicken pox have dropped dramatically, according to a study in the August 17 issue of JAMA. view more (2005-08-17)
UT School of Public Health researchers discover significant efficacy of travelers' diarrhea vaccine
Researchers at The University of Texas School of Public Health have found that patients given a travelers' diarrhea vaccine were significantly less likely to suffer from clinically significant diarrhea than those who received placebo, according to a study published in this week's edition of the Lancet. The patch-based vaccine is part of the Phase... view more... (2008-06-12)
Vaccination and testing for the human papilloma virus could eradicate cervical cancer
Cervical cancer could be eradicated within the next 50 years if countries implement national screening programmes based on detection of the human papilloma virus (HPV), which causes the disease, together with vaccination programmes against the virus, according to a cervical cancer screening expert. view more (2009-09-24)
UCSF brain tumor vaccine trial shows promising results
A vaccine for treating a recurrent cancer of the central nervous system that occurs primarily in the brain has shown promise in preliminary data from a clinical trial at the University of California, San Francisco. view more (2007-04-17)
Rotavirus Vaccine Found Not Guilty (pp 1197, 1224)
Worldwide, some 600 000 to 800 000 infants die yearly from severe diarrhoea caused by a rotavirus. In the USA, each year, about 50 000 infants are admitted to hospital with rotavirus infection, and of these about 20 die. These figures make a clear case for the need for a safe and effective vaccine against rotavirus infection. Such a vaccine... view more... (2001-10-10)
Human trial proves ricin vaccine safe, induces neutralizing antibodies; further tests planned
cientists have completed the first human clinical trial of a recombinant vaccine for the deadly toxin ricin-a potential bioterror threat - and the results indicate the vaccine is safe and effective in eliciting ricin-neutralizing antibodies. view more (2006-01-31)
Q-Fever: A global health risk
The decision to stop production of the vaccine for Q-Fever will leave Australia and the international community vulnerable to the health risks of Q-Fever infection, according to one of the country's leading researchers. view more (2005-12-01)
Increase seen in pneumococcal infections not covered by childhood vaccine
Alaska Native children are experiencing increased rates of serious infections caused by strains of pneumococcal bacteria that are not covered by the current childhood pneumococcal vaccine, indicating the importance of ongoing surveillance of vaccine effectiveness. view more (2007-04-25)
|
|
| Page
10 of
112 |
2229 Results |
|
|
|
Sort By:
Page Views | Date |
|
